Programmed Cell Death 1 Inhibitor
2 clinical trials · Condition
◉ Watch Programmed Cell Death 1 Inhibitor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients (NCT04473716) | Shanghai Jiao Tong University School of Medicine | 2020-07-30 |
| Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma (NCT04393506) | Shanghai Jiao Tong University School of Medicine | 2020-04-23 |
Track Programmed Cell Death 1 Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.